Blood Diseases Market Research Reports & Industry Analysis

Hemophilia Gene Therapy Market - Size, Share, Trends, and Forecast, 2022 - 2028 Hemophilia is a genetic disorder in which patient’s blood do not clot normally due to lack of blood-clotting proteins known as coagulating factors. Conventional treatment options include timely replacement of the specifi ...

Hemophilia Treatment Market - Global Industry Analysis (2019 - 2021) - Growth Trends and Market Forecast (2022 - 2027) Globally, the incidence of hemophilia has witnessed an uptick over the past few years. Classified as a rare disease, hemophilia occurs due to the absence/lack of a protein known as ...

2022 Global: Plasma Fractionation - Innovative Markets Forecast (2028) report The 2022 Global: Plasma Fractionation - Innovative Markets Forecast (2028) report analyzies the market size, projected growth/decline and regional data for the period 2017 through 2028. Perry/Hope Partners' reports provide ...

Thalassemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Drugs In Development, 2022, provides an overview of the Thalassemia (Hematological Disord ...

Global Biosimilars Market Size study, By Product (Monoclonal Antibodies, Insulin, Granulocyte Colony-Stimulating Factor, Erythropoietin, Recombinant Human Growth Hormone, Etanercept, Follitropin, Teriparatide, Interferons, Enoxaparin Sodium, Glucagon, Calcitonin), By Indication (Oncology, Inflammato ...

Blood and Blood Components Market Size By Product (Whole Blood, Blood Components {Red Blood Cells, Platelets, Plasma, White Blood Cells}), By Application (Anaemia, Trauma & Surgery, Cancer Treatment, Bleeding Disorders), By End-Use (Hospitals, Ambulatory Surgical Centres), Industry Analysis Report, ...

Iron Deficiency Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Iron Deficiency Anemia - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and ...

Global Hypereosinophilic Syndrome Market - 2022-2029 Market Overview The global hypereosinophilic syndrome market size was valued US$ XX million in 2020 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX% during the forecast period (2022-2029). Hypereosinophilic syndrome (HES) ...

The 2022 Global Forecast for Plasma Fractionation (2023-2028 Outlook)-High Tech & Emerging Markets Report , published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market for over 50 countries. The global market is expected to increase from USD xx billion in ...

DelveInsight’s, “ Chemotherapy Induced Anemia- Pipeline Insight, 2022 ,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Chemotherapy Induced Anemia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also ...

Hemophilia Treatment Market A recent market study published by Future Market Insights on the market offers global industry analysis for 2014-2021 & opportunity assessment for 2022–2032. The study offers a comprehensive assessment of the more important market dynamics. After conducting thorough resea ...

Global Hemophilia Market: Size, Trends & Forecast with Impact of COVID-19 (2022-2026)Scope of the Report The report titled “Global Hemophilia Market: Size, Trends & Forecast with Impact of COVID-19 (2022-2026)”, provides an in-depth analysis of global hemophilia market by value, by number of identif ...

Blood Plasma Derivatives Market by Product Type (Albumin, Anti-inhibitor Coagulation Factor, Factor VIII, Factor IX Concentrate, Immunoglobulins, Rh Immunoglobulin, Alpha 1-Protaese Inhibitor, and Anti–Thrombin), Application (HIV, Hemophilia A, Hemophilia B, Hepatitis C, Bleeding Disorders, Genetic ...

Hemophilia Treatment Market Size By Disease (Hemophilia A {Severe, Moderate, Mild}, Hemophilia B {Severe, Moderate, Mild}), By Product (Recombinant Factor Concentrates {Factor VIII, Factor IX}, Plasma-derived Factor Concentrates {Factor VIII, Factor IX}, Extended Half-life Products {Factor VIII, Fac ...

Plasma Derived Medicine Market, by Product Type (Albumin, Coagulation factors, Immunoglobulins, and Others), by Indication (Pelvic Inflammatory Disease (PID), Bleeding Disorders, Alpha-1 Antitrypsin Deficiency (AATD), Hereditary Angioedema (HAE), Chronic Inflammatory Demyelinating Polyneuropathy, Gu ...

Blood And Blood Components Global Market Report 2022 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global blood and blood components market. The report focuses on the blood and blood components market wh ...

Stem Cell/Cord Blood Banking Global Market Report 2022 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global stem cell/cord blood banking market. The report focuses on the stem cell/cord blood banking mar ...

Companion Diagnostics Market by Product (Assays, Kits, Software & Services), Technology (PCR, NGS, ISH, IHC), Indication (Breast, Blood, Lung, Colorectal Cancer, Neurology Diseases), End User (Pharma Companies, CROs), Region - Global Forecast to 2026 The global companion diagnostics market is projec ...

DelveInsight’s " Chemotherapy-induced anemia – Market Insights, Epidemiology, and Market Forecast – 2032 " report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the market trends of chemotherapy-induced anemia in the United States, EU5 (Germany, Spain, It ...

DelveInsight’s " Beta Thalassemia—Market Insights, Epidemiology, and Market Forecast–2032 " report deliver an in-depth understanding of Beta Thalassemia, historical and forecasted epidemiology as well as the market trends in the United States and EU5 (Germany, Spain, Italy, France, and United Kingdo ...

DelveInsight’s " Beta Thalassemia – Epidemiology Forecast–2032 " report delivers an in-depth understanding of Beta thalassemia historical and forecasted epidemiology in the United States and EU5 (Germany, Spain, Italy, France, and the United Kingdom). Beta Thalassemia Disease Understanding Beta Thal ...

DelveInsight’s, “ Aplastic Anemia - Pipeline Insight, 2022 ,” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Aplastic Anemia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutic ...

Hematology Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global hematology drugs market as it emerges from the C ...

DelveInsight’s " Chemotherapy Induced Anemia – Epidemiology Forecast – 2032 " report delivers an in-depth understanding of the historical and forecasted epidemiology of Chemotherapy Induced Anemia in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Chemother ...

Hemophilia Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) The Hemophilia market is expected to witness a CAGR of 5.9% during the forecast period (2021-2026). The outbreak of COVID-19 worldwide is expected to impact the market, as individuals with chronic medical conditions, su ...